K151578

Substantially Equivalent

Carbamazepine Gen 4

Applicant: Roche Diagnostics Operations (Rdo)
Product code: KLT
Advisory panel: Clinical Toxicology
Date received: 2015-06-11
Decision date: 2015-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.